The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
Coca-Cola Eyes Cannabis-Infused Drinks Market
Coke announced its interest after a report from Canada's BNN Bloomberg said the soda giant was in "serious talks" with Edmonton-based Aurora Cannabis, a medical marijuana producer and distributor, to develop drinks infused with cannabidiol, or CBD.
CBD, a cannabis extract that does not have the psychoactive elements of marijuana, is used to treat a variety of medical conditions and ailments.
The oil has boomed in popularity as a growing number of states and countries, including Canada, legalize sales of cannabis products for recreational use. The CBD market is forecast to grow to $2.1 billion by 2020, a dramatic increase from last year's market value of $202 million, according to Hemp Business Journal. Canadians can legally buy and consume cannabis starting this Oct. 17.
Coca-Cola and Aurora would likely develop drinks to ease inflammation, pain and cramping, the BNN report said. The beverages would be unlike the cannabis-infused drinks that beer makers are planning to produce that would likely give drinkers the same buzz from inhaling marijuana.
Coke is diversifying its product portfolio, with recent investments in the sparkling water category and coffee. Demand for sugary sodas has declined year upon year over the last decade as consumers become more health conscious.
In response to the BNN report, Coca-Cola said it has "no interest in marijuana or cannabis."
"Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world," the company added. "The space is evolving quickly. No decisions have been made at this time."
Following the BNN report, Aurora's stock spiked 17 percent and Coke's also jumped slightly, Reuters noted.
EcoWatch Daily Newsletter
An area in Louisiana whose predominantly black and brown residents are hard-hit by health problems from industry overdevelopment is experiencing one of the highest death rates from coronavirus of any county in the United States.
A central player in the fight against the novel coronavirus is our immune system. It protects us against the invader and can even be helpful for its therapy. But sometimes it can turn against us.
Calling someone a delicate flower may not sting like it used to, according to new research. Scientists have found that many delicate flowers are actually remarkably hearty and able to bounce back from severe injury.
With global air travel at a near standstill, the airline industry is looking to rewrite the rules it agreed to tackle global emissions. The Guardian reports that the airline is billing it as a matter of survival, while environmental activists are accusing the industry of trying to dodge their obligations.
The outbreak of COVID-19 across the U.S. has touched every facet of our society, and our democracy has been no exception.